Q&A with Jeanne Hopkins, CMO at Lola.com

MEDIA 7 | October 24, 2019

Jeanne Hopkins, CMO at Lola.com has profound expertise in data-driven, high-velocity customer acquisition and marketing organizations and inbound-based lead gen programs to support global demand for high-growth SaaS companies.

Jeanne is also the co-author of "Go Mobile"​, the #1 best-selling mobile marketing book. She has been named to Sales Lead Management Association "Top 50"​ 3 years in a row and "20 Women to Watch" in 2015/14/13 & 2011.

MEDIA 7: What inspired you to get into marketing?
JEANNE HOPKINS:
 After graduation, I took my first job in the accounting department at Baystate Medical Center. At my annual review, I was told that I was too “noisy” for an accounting department. I went on to work at Milton Bradley Company’s in-house advertising agency, MB Communications, as editor of their in-house newspaper, and later recruited to LEGO Systems to do marketing programs. I found myself at a self-funded start-up tech company in 2000, where I was running an inside sales team and building digital properties to generate leads. I moved into software, digital marketing, and lead generation at companies like MarketingSherpa, then HubSpot, SmartBear, Ipswitch (now Progress Software) – it’s all been a fantastic journey.

M7: How is agile technology transforming corporate travel around the globe?
JH:
Small and mid-sized businesses have to be fast and efficient amidst growth, and booking, re-booking, and managing business travel can seriously impede efficiency and productivity. Finance teams are trying to manage, control, and get visibility into expenditures. Travelers are trying to do their jobs and don’t have time for expense reports. And travel arrangers (executive assistants and office admins) have plenty on their plates. Finally, there are tools that are addressing these direct needs at small and mid-sized businesses. Consumers have had the ease of booking travel through sites like Kayak and big businesses can afford the services and fees associated with high-end travel agencies. But the middle segment has been left out. Now, agile tools like Lola.com are making it really easy for corporate travelers to book, re-book, and take the task of expense reports off the table. And finance teams are able to set up travel policies in minutes, and easily manage, control, and get visibility into expenditures. The corporate travel market is huge, and agile technology is making it much easier for travelers and companies all-around.


"The corporate travel market is huge, and agile technology is making it much easier for travelers and companies all-around."

M7: How does Lola.com ensure a hassle-free modern business travel experience with transparent spending for its customers / business travelers?
JH:
It’s a simple super app to use. For travelers, it has a large inventory of flights and hotels that allows users to avoid having to go between tabs or other sites to compare fares, and it saves preferences, loyalty programs, and payment options in the same place. Traveler profiles are automatically stored so users can book with one click, and the 24/7 support team ensures easy booking and re-booking due to delays and cancellations. Seriously, when someone is in the air, missing their connection due to a delay, many times, Lola.com support has them re-booked on another flight before they land.

For finance personnel, a corporate travel policy can be set up in five minutes for more control over spending, and employees automatically know what they are allowed to book. Takes the guesswork out of the booking process. All data resides in one place so there is complete visibility into travel spend. And we integrate with other tools like Expensify – receipts are automatically sent to Expensify for easy expense tracking and reporting. No messing with receipts (or missing receipts either).


"For finance personnel, a corporate travel policy can be set up in five minutes for more control over spending, and employees automatically know what they are allowed to book."

M7: What trends do you foresee in the ‘Travel & Expense Software Market’ in future?
JH:
Certainly, we are seeing “Bleisure” travel on the rise – those looking to combine business travel with leisure time. Busy people who travel with their jobs want to get the most out a business trip, and many times, even look to extend a business trip last minute to enjoy the area or do something in particular. So companies are looking for faster, agile tools that can respond to quick changes in plans. Companies are also focusing more on keeping their travelers happy and productive on the road, and don’t want them to get caught up in the red tape of corporate travel. So, the trend is simple, faster, more agile tools to make arranging and managing travel a great experience for all.

M7: As the co-author of ‘Go Mobile’, what tactics do you believe modern marketers must focus for successful mobile media marketing campaigns?
JH:  
That book was launched in 2012 and was probably ahead of its time. While at HubSpot seven years ago, I saw the growing influence of mobile search on our blog and website and wanted to make sure we recognized its impact. Today, marketers know that Google prioritizes mobile search and it is imperative to truly understand the need for content that can be delivered in a mobile setting. The ability to auto-fill a form is critical now. The ability to read your email and respond is imperative now. The ability to print from your phone is important - whether an eBook, a recipe or instructions. Your mobile device is your computer now. It wasn’t perceived as that urgent a requirement until 18-24 months ago.


"Companies are focusing more on keeping their travelers happy and productive on the road, and don’t want them to get caught up in the red tape of corporate travel. So, the trend is simple, faster, more agile tools to make arranging and managing travel a great experience for all."

M7: What is your favorite part of working at Lola.com?
JH:
The people. Transparently, everyone really values working alongside each other – all smart, motivated, driven, fun teammates who want to make Lola.com the best workplace ever.  I take a quote from Netflix on how I feel, “Loosely coupled yet tightly aligned.”

M7: What is your superpower or spirit animal?
JH:
 GSD. I just like to get stuff done. I use lists, reminders, notes, etc. to try and stay on top of all that needs to be done. More than anything, I want my team and the company to be successful. I enjoy working, and I enjoy success and - most of all - I enjoy making mistakes and sharing what I did so that others realize that you won’t die from a typo. It’s all fun and I enjoy laughing most of all (remember, I am a loud individual).

ABOUT LOLA.COM

Lola.com makes Agile Travel Management real by providing a super simple way to manage, book and report on business travel, saving employers and travelers time and money. Happy employee travel experiences within a policy can be set up in five minutes. Lola.com uses machine learning and 24/7 support to help travelers easily book trips, while empowering managers to create policies, view budgets and expenditures, and monitor their globetrotting team efficiently. Based in Boston, the company was founded in 2015 by Paul English, co-founder of the travel booking site KAYAK, and is led by CEO Mike Volpe, previously CMO at HubSpot. For more information, connect on LinkedIn, Twitter, Instagram and Facebook.

More C-Suite on deck

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Q&A with Bill Gianoukos, CEO at Goodpath

Media 7 | September 14, 2021

Bill Gianoukos, Co-founder and CEO of Goodpath, started Goodpath in 2018 with a mission to improve the ‘Quality Of Life’ for those suffering from chronic conditions. He is also a Mentor at Techstars, and an Investor at Wappier: Intelligent Revenue Management.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Q&A with Bill Gianoukos, CEO at Goodpath

Media 7 | September 14, 2021

Bill Gianoukos, Co-founder and CEO of Goodpath, started Goodpath in 2018 with a mission to improve the ‘Quality Of Life’ for those suffering from chronic conditions. He is also a Mentor at Techstars, and an Investor at Wappier: Intelligent Revenue Management.

Read More

Related News

HEALTH TECHNOLOGY, MEDICAL DEVICES

Temple Health and Masimo Advance Patient Care Through Innovation Collaboration

Masimo | March 10, 2023

Masimo, a pioneer in technology and automation solutions for the healthcare industry, and Temple Health, a leading academic health system in Philadelphia, recently announced the formation of a strategic innovation collaboration. With a focus on advancing the forefront of telehealth and remote patient monitoring and automating high-quality care, the strategic partnership may involve using innovations such as the Radius VSMTM tetherless multimodal patient monitor, Masimo W1TM advanced health tracking watch, and various Masimo Hospital AutomationTM solutions. The collaboration aims to advance the organizations’ shared objectives of increasing care value, improving health, and transforming care delivery models. Masimo and Temple Health intend to collaborate in the following areas Raising awareness about health equity using their expertise and regional influence to improve access to quality care for Philadelphia residents. Demonstrating the future of healthcare by deploying next-generation therapies, devices, technologies, and systems to enhance patient-centered care across the care continuum, particularly in remote patient monitoring, automation, and telehealth. Joint research into healthcare technology best practices to minimize tech obsolesce in healthcare as telehealth and automation infrastructure become more sophisticated. Trial and refine the latest Masimo technologies by participating in the Temple Health ‘Collaboratory.’ Collaborative clinical research in inpatient, outpatient, and home settings, with technological innovation, cooperation and co-development. Key leaders’ engagement in clinical and technological exchanges aimed at pushing the frontiers of healthcare. Founder and CEO of Masimo, Joe Kiani, shared, “We are delighted to expand our relationship with Temple Health through this innovation collaboration and to work hand in hand to explore how Masimo’s monitoring, connectivity, and automation technologies, alongside Temple Health’s clinical expertise, can bring safe, easy-to-use, high-quality telehealth and remote patient monitoring services to their patients. We are committed to improving life, improving patient outcomes, and reducing the cost of care.” (Source – Business Wire) About Masimo Based in Irvine, California, Masimo is a global medical technology company specializing in developing and manufacturing breakthrough noninvasive patient monitoring technologies, including sensors and medical devices. For over 30 years, it has been dedicated to solving challenging problems in the medical industry. By offering clinically-proven and innovative products, and healthcare providers, the company is committed to making a measurable difference in the world by saving, prolonging, and enhancing the lives of people of every age and background. Its cutting-edge solutions offer real-time information to optimize clinical decision-making and improve patient safety.

Read More

HEALTH TECHNOLOGY

Netherlands Healthcare Extends Sectra Contract, Adopts Cloud Service

Sectra | March 16, 2023

Sectra, a global healthcare IT leader, informed on March 15, 2023, that it has renewed its contract with Dutch hospital Zuyderland for another ten years. Sectra One Cloud, a cloud-based version of its enterprise imaging product, is included in the arrangement, offering Zuyderland a scalable, secure, and professionally managed service. With Sectra managing the infrastructure, healthcare practitioners can focus on delivering exceptional patient care. Ralph Berendsen, Medical Physicist at Zuyderland Medical Center, stated, "Our current infrastructure needs to be replaced, giving us the perfect opportunity to move over to Sectra's cloud solution." He added, "We've been a happy customer of Sectra for many years, so letting them take full responsibility for our IT operations was an easy choice. Moving to the cloud will reduce our IT burden, giving us the time to focus on our users." (Source – Cision PR Newswire) The radiology, nuclear medicine, and orthopedic departments of Zuyderland Medical Center are in Sittard-Geleen and Heerlen. The company, which has been using Sectra's solution since 2017, will be the first Dutch company to adopt Sectra One Cloud, developed in Microsoft Azure. Peter Osinga, Managing Director, Sectra Benelux and DACH, remarked, "Many healthcare providers are currently facing challenges when it comes to high workloads and a lack of resources. In addition, secure communication and sharing of sensitive data has never been more important. As a result, we are seeing increasing interest in cloud services." He added, "I'm happy that Zuyderland remains satisfied with us as their technology provider, and I am proud of being trusted to manage their IT infrastructure." (Source – Cision PR Newswire) This contract, which includes radiology, breast imaging, and orthopedics, was finalized in February 2023. About Sectra Sectra strives to promote a better and more secure society by assisting health systems worldwide in improving care efficiency and helping European authorities and defense forces preserve sensitive information. Founded in 1978, the company's headquarters are in Linköping (Sweden). With global distribution partners, it conducts direct sales in 19 countries.

Read More

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

Rhythmlink Announces Investment Partnership With Graham Partners

Rhythmlink | March 20, 2023

Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses. As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues along with the innovation and quality that Rhythmlink is known for. The investment was completed on March 15, 2023. “We’re excited about this next phase of Rhythmlink,” said Shawn Regan, CEO and Co-Founder. “Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities,” said Regan. “I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics.” This new relationship with Graham follows Rhythmlink’s extremely successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. Under partnership with New Heritage Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded their existing product line to include EMG and NCV diagnostic consumable devices. Joe Straczek, COO and CFO for Rhythmlink, spoke on the success of this relationship. “Our partnership with New Heritage was extremely beneficial,” said Straczek. “With their support, both financially and strategically, we were able to realize significant growth, particularly with the acquisition of Chalgren. We are immensely grateful for their partnership and guidance over the last four years.” Rhythmlink sells a full line of consumable neurodiagnostic devices for Critical Care, electroencephalography, intraoperative neuromonitoring, the ER and ICU, and long-term epilepsy monitoring. About Rhythmlink Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by transforming medical device technology that links patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services. About Graham Partners Graham Partners is a private investment firm focused on investing in technology-driven companies that are spurring innovation in advanced manufacturing, resulting in product substitutions, raw materials conversions, and disruptions to traditional end markets. Graham Partners can offer control or minority capital solutions and typically targets companies with EBITDA up to $50 million. Since the firm's founding in 1988 by Steven Graham, Graham Partners has closed over 150 acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham Partners funds together with Graham-led co-investments totals approximately $4.0 billion as of December 31, 2022, which differs from Graham’s Regulatory Assets Under Management of approximately $2.2 billion as of December 31, 2022. Investors include high-net-worth individuals, college and university endowments, foundations, public and private pension plans, funds-of-funds, and other institutional investors. Based in suburban Philadelphia, the firm has access to extensive operating resources and industrial expertise and is a member of The Graham Group, an alliance of independent operating Graham Partners Inc. businesses, investment firms and philanthropic entities, which all share in the common legacy of entrepreneur Donald Graham.

Read More

HEALTH TECHNOLOGY, MEDICAL DEVICES

Temple Health and Masimo Advance Patient Care Through Innovation Collaboration

Masimo | March 10, 2023

Masimo, a pioneer in technology and automation solutions for the healthcare industry, and Temple Health, a leading academic health system in Philadelphia, recently announced the formation of a strategic innovation collaboration. With a focus on advancing the forefront of telehealth and remote patient monitoring and automating high-quality care, the strategic partnership may involve using innovations such as the Radius VSMTM tetherless multimodal patient monitor, Masimo W1TM advanced health tracking watch, and various Masimo Hospital AutomationTM solutions. The collaboration aims to advance the organizations’ shared objectives of increasing care value, improving health, and transforming care delivery models. Masimo and Temple Health intend to collaborate in the following areas Raising awareness about health equity using their expertise and regional influence to improve access to quality care for Philadelphia residents. Demonstrating the future of healthcare by deploying next-generation therapies, devices, technologies, and systems to enhance patient-centered care across the care continuum, particularly in remote patient monitoring, automation, and telehealth. Joint research into healthcare technology best practices to minimize tech obsolesce in healthcare as telehealth and automation infrastructure become more sophisticated. Trial and refine the latest Masimo technologies by participating in the Temple Health ‘Collaboratory.’ Collaborative clinical research in inpatient, outpatient, and home settings, with technological innovation, cooperation and co-development. Key leaders’ engagement in clinical and technological exchanges aimed at pushing the frontiers of healthcare. Founder and CEO of Masimo, Joe Kiani, shared, “We are delighted to expand our relationship with Temple Health through this innovation collaboration and to work hand in hand to explore how Masimo’s monitoring, connectivity, and automation technologies, alongside Temple Health’s clinical expertise, can bring safe, easy-to-use, high-quality telehealth and remote patient monitoring services to their patients. We are committed to improving life, improving patient outcomes, and reducing the cost of care.” (Source – Business Wire) About Masimo Based in Irvine, California, Masimo is a global medical technology company specializing in developing and manufacturing breakthrough noninvasive patient monitoring technologies, including sensors and medical devices. For over 30 years, it has been dedicated to solving challenging problems in the medical industry. By offering clinically-proven and innovative products, and healthcare providers, the company is committed to making a measurable difference in the world by saving, prolonging, and enhancing the lives of people of every age and background. Its cutting-edge solutions offer real-time information to optimize clinical decision-making and improve patient safety.

Read More

HEALTH TECHNOLOGY

Netherlands Healthcare Extends Sectra Contract, Adopts Cloud Service

Sectra | March 16, 2023

Sectra, a global healthcare IT leader, informed on March 15, 2023, that it has renewed its contract with Dutch hospital Zuyderland for another ten years. Sectra One Cloud, a cloud-based version of its enterprise imaging product, is included in the arrangement, offering Zuyderland a scalable, secure, and professionally managed service. With Sectra managing the infrastructure, healthcare practitioners can focus on delivering exceptional patient care. Ralph Berendsen, Medical Physicist at Zuyderland Medical Center, stated, "Our current infrastructure needs to be replaced, giving us the perfect opportunity to move over to Sectra's cloud solution." He added, "We've been a happy customer of Sectra for many years, so letting them take full responsibility for our IT operations was an easy choice. Moving to the cloud will reduce our IT burden, giving us the time to focus on our users." (Source – Cision PR Newswire) The radiology, nuclear medicine, and orthopedic departments of Zuyderland Medical Center are in Sittard-Geleen and Heerlen. The company, which has been using Sectra's solution since 2017, will be the first Dutch company to adopt Sectra One Cloud, developed in Microsoft Azure. Peter Osinga, Managing Director, Sectra Benelux and DACH, remarked, "Many healthcare providers are currently facing challenges when it comes to high workloads and a lack of resources. In addition, secure communication and sharing of sensitive data has never been more important. As a result, we are seeing increasing interest in cloud services." He added, "I'm happy that Zuyderland remains satisfied with us as their technology provider, and I am proud of being trusted to manage their IT infrastructure." (Source – Cision PR Newswire) This contract, which includes radiology, breast imaging, and orthopedics, was finalized in February 2023. About Sectra Sectra strives to promote a better and more secure society by assisting health systems worldwide in improving care efficiency and helping European authorities and defense forces preserve sensitive information. Founded in 1978, the company's headquarters are in Linköping (Sweden). With global distribution partners, it conducts direct sales in 19 countries.

Read More

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

Rhythmlink Announces Investment Partnership With Graham Partners

Rhythmlink | March 20, 2023

Rhythmlink International, LLC is pleased to announce an exciting new investment partnership with Graham Partners, a Pennsylvania-based private equity firm that specializes in industrial technology and advanced manufacturing businesses. As a market leading designer and manufacturer of disposable neurodiagnostic devices and consumables, Rhythmlink has experienced significant growth since its founding in 2002, and this investment from Graham will ensure that growth continues along with the innovation and quality that Rhythmlink is known for. The investment was completed on March 15, 2023. “We’re excited about this next phase of Rhythmlink,” said Shawn Regan, CEO and Co-Founder. “Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities,” said Regan. “I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics.” This new relationship with Graham follows Rhythmlink’s extremely successful partnership with New Heritage Capital, a Boston-based private equity firm that invested in Rhythmlink in 2019. Under partnership with New Heritage Rhythmlink grew rapidly, acquired Chalgren Enterprises and expanded their existing product line to include EMG and NCV diagnostic consumable devices. Joe Straczek, COO and CFO for Rhythmlink, spoke on the success of this relationship. “Our partnership with New Heritage was extremely beneficial,” said Straczek. “With their support, both financially and strategically, we were able to realize significant growth, particularly with the acquisition of Chalgren. We are immensely grateful for their partnership and guidance over the last four years.” Rhythmlink sells a full line of consumable neurodiagnostic devices for Critical Care, electroencephalography, intraoperative neuromonitoring, the ER and ICU, and long-term epilepsy monitoring. About Rhythmlink Rhythmlink International is a medical device manufacturing company specializing in devices that help connect patients to machines to record or elicit physiologic information. Rhythmlink designs, manufactures and distributes a variety of medical devices for intraoperative neuromonitoring, electroencephalography, evoked potentials, polysomnography, long-term monitoring epilepsy and critical care units. Founded by neurodiagnostic technologists and engineers in 2002, Rhythmlink enhances patient care worldwide by transforming medical device technology that links patients to equipment. Rhythmlink also offers custom packaging, custom products, private labeling and contract manufacturing services. About Graham Partners Graham Partners is a private investment firm focused on investing in technology-driven companies that are spurring innovation in advanced manufacturing, resulting in product substitutions, raw materials conversions, and disruptions to traditional end markets. Graham Partners can offer control or minority capital solutions and typically targets companies with EBITDA up to $50 million. Since the firm's founding in 1988 by Steven Graham, Graham Partners has closed over 150 acquisitions, joint ventures, financings, and divestitures. The committed capital raised since inception through the Graham Partners funds together with Graham-led co-investments totals approximately $4.0 billion as of December 31, 2022, which differs from Graham’s Regulatory Assets Under Management of approximately $2.2 billion as of December 31, 2022. Investors include high-net-worth individuals, college and university endowments, foundations, public and private pension plans, funds-of-funds, and other institutional investors. Based in suburban Philadelphia, the firm has access to extensive operating resources and industrial expertise and is a member of The Graham Group, an alliance of independent operating Graham Partners Inc. businesses, investment firms and philanthropic entities, which all share in the common legacy of entrepreneur Donald Graham.

Read More

Spotlight

Lola.com

Lola.com

Lola.com makes Agile Travel Management real by providing a super simple way to manage, book and report on business travel, saving employers and travelers time and money. Happy employee travel experiences within a policy can be set up in five minutes. Lola.com uses machine learning and 24/7 support t...

Events

Resources